Abstract:Liying Chen, 1, &ast Dingqi Lu, 2, &ast Kai Yu, 1 Shiya He, 1 Liu Liu, 1 Xvfeng Zhang, 1 Bo Feng, 3 Xinchang Wang 4 1 Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People's Republic of China; 2 First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People's Republic of China; 3 Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, Zhejiang Province, 314001, People's Republic of China; 4 Department of Rheumatology, The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310005, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xinchang Wang Department of Rheumatology, The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China Tel +86 13065714635 Email Purpose: Sjögren's syndrome (SS) is a systemic autoimmune disease mainly characterized by dysfunction of exocrine glands. Studies on diagnosis models specific for SS patients are very limited. We aimed to use gene expression datasets from salivary glands to identify aberrant differentially expressed genes (DEGs) and pathways by bioinformatics and validate candidate genes by clinical minor labial gland biopsy (MSGB) samples, and finally build a combined gene quantitative diagnosis model of SS. Patients and Methods: Original datasets GSE23117, GSE7451, and GSE127952 were obtained from the Gene Expression Omnibus database (GEO) and integrated and analyzed for differentially expressed genes in SS salivary glands. ClueGO and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of upregulated and downregulated DEGs were performed, and protein–protein interaction (PPI) networks were constructed using the STRING and Cytoscape database. H&E staining and immunohistochemistry were used to validate the expression levels of four hub genes in salivary glands. Finally, a receiver operating characteristic (ROC) curve of the combined diagnosis of four hub genes was analyzed in SS patients and non-SS patients in order to explore the diagnostic efficacy of these genes compared with conventional FS in SS. Results: Fifty-three upregulated genes and fifteen downregulated genes were identified. We analyzed the expression and function of four hub genes via H&E, immunohistochemistry, and ROC analysis. We then evaluated and verified the diagnosis value of four hub genes, STAT1, MNDA, IL10RA , and CCR1 in MSGB of SS and non-SS. A combined diagnosis model of four indicators was established to identify patients' discrete data on the foci size (AUC=0.915). Conclusion: The expression of STAT1, MNDA , and IL10RA may be potential biological indicators for SS diagnosis. Compared with FS, a combined diagnosis model of quantitative gene expression could potentially contribute to improving the sensitivity and specificity of MSGB of SS. Keywords: Sjogren's syndrome, bioinformatics analysis, hub genes, validation, diagnostic performance, focus score Graphical Sjogren's syndrome (SS) is a systemic autoimmune disease primarily characterized by epithelitis in exocrine glands and the development of specific antibodies to SSA/SSB. Europe, North America, and Asia have a wide range of incidence rates for SS, and the prevalence rate in the population of three continents is 60.82 persons per 100,000 inhabitants, 1 and the female versus male ratio is 14:1. Patients with SS typically present with dry mouth and eyes, joint pain, and fatigue. 2,3 50% of patients present with systemic damage, and they have a 10–20-fold increased risk of developing B cell lymphoma. 4 The etiology and pathogenesis of the characteristic progressive glandular dysfunction in SS have not been fully clarified. Genetic susceptibility, environmental factors, and immune disorders are thought to play a dominant role. Studies have found that susceptibility genes, such as human leukocyte antigen ( HLA ), Interferon Regulatory Factor 5 ( IRF5 ), BLK , Interleukin 12A ( IL12A ), TNFAIP3 interaction protein 1 ( TNIP1 ), and Chemokine receptor 5 ( CXCR5 ), are closely related to the occurrence of SS. 5 Activation of the type I interferon pathway, infiltration of T and B lymphocytes, and formation of ectopic germinal centers within salivary glands all cause damage in multiple tissues. 6 The histopathology of salivary glan -Abstract Truncated-

Identification and Validation of IFI44 as a Novel Biomarker for Primary Sjögren's Syndrome

Biomarkers for Primary Sjögren’s Syndrome

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Identification and Verification of Inflammatory Biomarkers for Primary Sjögren’s Syndrome

IFIH1 Was Predicted As a Key Biomarker in Primary Sjögren's Syndrome Based on Transcriptome Analysis and Experimental Verification in Patients and Mice

Biomarkers of Interstitial Lung Disease Associated with Primary Sjögren's Syndrome.

Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome

Bioinformatics Analysis for Identification of Key Genes in Salivary Gland and the Potential of a Combination of Biomarkers for the Diagnosis of SS

Shared biomarkers of multi-tissue origin for primary Sjogren's syndrome and their importance in immune microenvironment alterations

AB0020 Differentially Expressed Genes in Sjgren’s Syndrome Microarray

Non-invasive diagnosis of primary Sjögren's syndrome using ultrasonography and transcriptome biomarkers

POS0109 IDENTIFICATION OF PRIMARY SJOGREN’S SYNDROME SUBTYPES BY MACHINE LEARNING

OP0185 Characteristics of Primary Sjögren's Syndrome Patients with IGG4-Positive Plasma Cells in Labial Salivary Glands

Serum biomarker-based risk model construction for primary Sjögren's syndrome with interstitial lung disease

Identification of inflammatory markers as indicators for disease progression in primary Sjögren syndrome

Differential long non-coding RNA expression profile and function analysis in primary Sjogren’s syndrome

Identification and verification of inflammatory biomarkers for primary Sjögren's syndrome

Association Between IFN-α and Primary Sjogren's Syndrome

Analysis of Gene Expression and TCR/B Cell Receptor Profiling of Immune Cells in Primary Sjögren's Syndrome by Single-Cell Sequencing.

Clinical Significance of the Expression Levels of Serum Transforming Growth Factor-Β and CXC Type Chemokine Ligand 13 in Primary Sjogren's Syndrome Patients.

CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations